These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33952308)

  • 1. The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening.
    Rosende-Roca M; Abdelnour C; Esteban E; Tartari JP; Alarcon E; Martínez-Atienza J; González-Pérez A; Sáez ME; Lafuente A; Buendía M; Pancho A; Aguilera N; Ibarria M; Diego S; Jofresa S; Hernández I; López R; Gurruchaga MJ; Tárraga L; Valero S; Ruiz A; Marquié M; Boada M
    Alzheimers Res Ther; 2021 May; 13(1):95. PubMed ID: 33952308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences and the role of education in cognitive ageing: analysis of two UK-based prospective cohort studies.
    Bloomberg M; Dugravot A; Dumurgier J; Kivimaki M; Fayosse A; Steptoe A; Britton A; Singh-Manoux A; Sabia S
    Lancet Public Health; 2021 Feb; 6(2):e106-e115. PubMed ID: 33516287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.
    Roe CM; Xiong C; Miller JP; Morris JC
    Neurology; 2007 Jan; 68(3):223-8. PubMed ID: 17224578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis.
    Martinkova J; Quevenco FC; Karcher H; Ferrari A; Sandset EC; Szoeke C; Hort J; Schmidt R; Chadha AS; Ferretti MT
    JAMA Netw Open; 2021 Sep; 4(9):e2124124. PubMed ID: 34515784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Driven Differences in the Effectiveness of Individualized Clinical Management of Alzheimer's Disease Risk.
    Saif N; Hristov H; Akiyoshi K; Niotis K; Ariza IE; Malviya N; Lee P; Melendez J; Sadek G; Hackett K; Rahman A; Meléndez-Cabrero J; Greer CE; Mosconi L; Krikorian R; Isaacson RS
    J Prev Alzheimers Dis; 2022; 9(4):731-742. PubMed ID: 36281678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
    Teng E; Manser PT; Shah M; Pickthorn K; Hu N; Djakovic S; Swendsen H; Blendstrup M; Faccin G; Ostrowitzki S; Sink KM
    J Prev Alzheimers Dis; 2023; 10(1):41-49. PubMed ID: 36641609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility of Alzheimer's disease clinic patients for clinical trials.
    Schneider LS; Olin JT; Lyness SA; Chui HC
    J Am Geriatr Soc; 1997 Aug; 45(8):923-8. PubMed ID: 9256842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of mild cognitive impairment and Alzheimer's disease in arabic villages in northern Israel: impact of gender and education.
    Afgin AE; Massarwa M; Schechtman E; Israeli-Korn SD; Strugatsky R; Abuful A; Farrer LA; Friedland RP; Inzelberg R
    J Alzheimers Dis; 2012; 29(2):431-9. PubMed ID: 22233764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Projects for Patients with Dementia and Their Caregivers.
    Tsolaki M; Makri M; Tsatali M; Teichmann Β
    Adv Exp Med Biol; 2023; 1425():609-618. PubMed ID: 37581834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dementia in rural China: impact of age, gender and education.
    Zhou DF; Wu CS; Qi H; Fan JH; Sun XD; Como P; Qiao YL; Zhang L; Kieburtz K
    Acta Neurol Scand; 2006 Oct; 114(4):273-80. PubMed ID: 16942548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia.
    Buckwalter JG; Rizzo AA; McCleary R; Shankle R; Dick M; Henderson VW
    Arch Neurol; 1996 May; 53(5):436-9. PubMed ID: 8624219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    Yuan J; Maserejian N; Liu Y; Devine S; Gillis C; Massaro J; Au R
    J Alzheimers Dis; 2021; 79(2):807-817. PubMed ID: 33361590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
    Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
    J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.